For instance, the downregulation of hnRNPA2/B1 suppressed the activation of the STAT3 pathway, inhibiting proliferation and in vivo tumorigenicity of breast cancer cells [125,126]. The gene discussed is HNRNPA2B1; the disease is breast carcinoma.